Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Hyped Up Stocks That Concern Us

By: StockStory

January 18, 2026 at 23:40 PM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

TXG Cover Image

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. All that said, here are three stocks getting more buzz than they deserve and some you should buy instead.

10x Genomics (TXG)

One-Month Return: +27.5%

Founded in 2012 by scientists seeking to overcome limitations in traditional biological research methods, 10x Genomics (NASDAQ: TXG) develops instruments, consumables, and software that enable researchers to analyze biological systems at single-cell resolution and spatial context.

Why Are We Hesitant About TXG?

Sales trends were unexciting over the last two years as its 4.2% annual growth was below the typical healthcare company
Negative free cash flow raises questions about the return timeline for its investments
Push for growth has led to negative returns on capital, signaling value destruction

10x Genomics is trading at $20.47 per share, or 4.4x forward price-to-sales. Read our free research report to see why you should think twice about including TXG in your portfolio.

Northern Trust (NTRS)

One-Month Return: +4.3%

Founded in 1889 during Chicago's post-Great Fire rebuilding boom, Northern Trust (NASDAQ: NTRS) provides wealth management, asset servicing, and banking solutions to corporations, institutions, families, and high-net-worth individuals globally.

Why Is NTRS Not Exciting?

Muted 5.2% annual revenue growth over the last five years shows its demand lagged behind its financials peers
Earnings per share lagged its peers over the last five years as they only grew by 6.6% annually

At $145.49 per share, Northern Trust trades at 15.6x forward P/E. To fully understand why you should be careful with NTRS, check out our full research report (it’s free).

Stifel (SF)

One-Month Return: +0.7%

Tracing its roots back to 1890 when the firm was established in St. Louis, Stifel Financial (NYSE: SF) is a financial services firm that provides wealth management, investment banking, and institutional brokerage services to individuals, corporations, and institutions.

Why Does SF Fall Short?

Earnings growth underperformed the sector average over the last five years as its EPS grew by just 9% annually
6.1% annual book value per share growth over the last two years was slower than its financials peers

Stifel’s stock price of $128.25 implies a valuation ratio of 14x forward P/E. Check out our free in-depth research report to learn more about why SF doesn’t pass our bar.

High-Quality Stocks for All Market Conditions

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	265.29	-1.03 (-0.39%)
AAPL	308.33	-0.49 (-0.16%)
AMD	503.89	+36.38 (7.78%)
BAC	52.20	+0.40 (0.77%)
GOOG	384.84	+5.46 (1.44%)
META	612.34	+2.08 (0.34%)
MSFT	416.03	-2.54 (-0.61%)
NVDA	214.86	-0.47 (-0.22%)
ORCL	193.06	+0.98 (0.51%)
TSLA	433.59	+7.58 (1.78%)